Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano
  • Pembrolizumab-associated ex...
    Said, Jordan T; Iriarte, Christopher; Talia, Jordan; Leung, Bonnie; Virgen, Cesar A; Robertson, Matthew; Rabin, Michael S; Larocca, Cecilia; LeBoeuf, Nicole R

    Clinical and experimental dermatology, 08/2023, Letnik: 48, Številka: 9
    Journal Article

    Immune checkpoint inhibition (ICI) can induce progression of pre-existing radiation-induced morphoea beyond the irradiated field and into deeper structures including the muscle and fascia. Dupilumab, an interleukin-4 receptor antagonist, should be considered in patients with refractory radiation or ICI-induced morphoea and may allow for continued anticancer treatment.